Cargando…

A silica-based pH-sensitive nanomatrix system improves the oral absorption and efficacy of incretin hormone glucagon-like peptide-1

BACKGROUND: Glucagon-like peptide-1 (GLP-1) (7–36) is a peptide incretin hormone released from the endocrine L-cells of the intestinal mucosa with unique antidiabetic potential. Due to low absorption efficiency and instability in the gastrointestinal tract, the introduction of orally active GLP-1 is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qu, Wei, Li, Yong, Hovgaard, Lars, Li, Song, Dai, Wenbin, Wang, Jiancheng, Zhang, Xuan, Zhang, Qiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2012
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446861/ https://www.ncbi.nlm.nih.gov/pubmed/23028226 http://dx.doi.org/10.2147/IJN.S30013

Ejemplares similares

Glucagon-like peptide 1 and dysglycemia: Conflict in incretin science
por: Singh, Awadhesh Kumar
Publicado: (2015)

Degradation of the Incretin Hormone Glucagon-Like Peptide-1 (GLP-1) by Enterococcus faecalis Metalloprotease GelE
por: LeValley, Stephanie L., et al.
Publicado: (2020)

Enhancing Anti-Tumor Activity of Sorafenib Mesoporous Silica Nanomatrix in Metastatic Breast Tumor and Hepatocellular Carcinoma via the Co-Administration with Flufenamic Acid
por: Li, Zhuo-Yue, et al.
Publicado: (2020)

Relevance of Autophagy Induction by Gastrointestinal Hormones: Focus on the Incretin-Based Drug Target and Glucagon
por: Kanasaki, Keizo, et al.
Publicado: (2019)

Improving anti-tumor activity of sorafenib tosylate by lipid- and polymer-coated nanomatrix
por: Guo, Yang, et al.
Publicado: (2017)

Targeting the Incretin/Glucagon System With Triagonists to Treat Diabetes
por: Capozzi, Megan E, et al.
Publicado: (2018)

The incretin/glucagon system as a target for pharmacotherapy of obesity
por: Del Prato, Stefano, et al.
Publicado: (2021)

Elevated circulating levels of an incretin hormone, glucagon-like peptide-1, are associated with metabolic components in high-risk patients with cardiovascular disease
por: Yamaoka-Tojo, Minako, et al.
Publicado: (2010)

The incretin hormone glucagon‐like peptide 1 increases mitral cell excitability by decreasing conductance of a voltage‐dependent potassium channel
por: Thiebaud, Nicolas, et al.
Publicado: (2016)

Enteral supplementation with glutamine, fiber, and oligosaccharide modulates incretin and glucagon-like peptide-2 secretion
por: Joo, Erina, et al.
Publicado: (2015)

Glucose‐dependent insulinotropic polypeptide and glucagon‐like peptide‐1: Incretin actions beyond the pancreas
por: Seino, Yutaka, et al.
Publicado: (2013)

Acylation of the Incretin Peptide Exendin-4 Directly Impacts Glucagon-Like Peptide-1 Receptor Signaling and Trafficking
por: Lucey, Maria, et al.
Publicado: (2021)

Lixisenatide: A New Member of the Glucagon-Like Peptide 1 Receptor Agonist Class of Incretin Therapies
por: Shaefer, Charles F.
Publicado: (2016)

Incretin concept revised: The origin of the insulinotropic function of glucagon‐like peptide‐1 – the gut, the islets or both?
por: Yabe, Daisuke, et al.
Publicado: (2017)

Enhanced MIN-6 beta cell survival and function on a nitric oxide-releasing peptide amphiphile nanomatrix
por: Lim, Dong-Jin, et al.
Publicado: (2014)

Incretin hormones as immunomodulators of atherosclerosis
por: Alonso, Nuria, et al.
Publicado: (2012)

Incretin hormones and the satiation signal
por: Holst, J J
Publicado: (2013)

The Links of Ghrelin to Incretins, Insulin, Glucagon, and Leptin After Bariatric Surgery
por: Skuratovskaia, Daria, et al.
Publicado: (2021)

Biocompatibility Computation of Muscle Cells on Polyhedral Oligomeric Silsesquioxane-Grafted Polyurethane Nanomatrix
por: Amna, Touseef, et al.
Publicado: (2021)

Leucine (and lysine) increased plasma levels of the satiety hormone cholecystokinin (CCK), and phenylalanine of the incretin glucagon-like peptide 1 (GLP-1) after oral gavages in pigs
por: Müller, Maximiliano, et al.
Publicado: (2023)

Bone: Incretin Hormones Perceiver or Receiver?
por: Dicembrini, Ilaria, et al.
Publicado: (2012)

Molecular mechanisms of incretin hormone secretion()
por: Ezcurra, Marina, et al.
Publicado: (2013)

Incretin hormones and type 2 diabetes
por: Nauck, Michael A., et al.
Publicado: (2023)

Evaluation of ciprofloxacin and metronidazole encapsulated biomimetic nanomatrix gel on Enterococcus faecalis and Treponema denticola
por: Kaushik, Sagar N, et al.
Publicado: (2015)

The Change in Glucagon Following Meal Ingestion Is Associated with Glycemic Control, but Not with Incretin, in People with Diabetes
por: Yoo, Soyeon, et al.
Publicado: (2021)

UV-activated multilayer nanomatrix provides one-step tunable carbohydrate structural characterization in MALDI-MS
por: Obena, Rofeamor P., et al.
Publicado: (2015)

Nutrient detection by incretin hormone secreting cells
por: Diakogiannaki, Eleftheria, et al.
Publicado: (2012)

Incretin Effect of Glucagon-Like Peptide 1 Receptor Agonist Is Preserved in Presence of ABCC8/SUR1 Mutation in β-Cell
por: Bourron, Olivier, et al.
Publicado: (2012)

Effects of the nitric oxide releasing biomimetic nanomatrix gel on pulp-dentin regeneration: Pilot study
por: Moon, Chan-Yang, et al.
Publicado: (2018)

Doxycycline-Loaded Nitric Oxide-Releasing Nanomatrix Gel in Replanted Rat Molar on Pulp Regeneration
por: Yun, Kwan-Hee, et al.
Publicado: (2021)

Angiogenic and Osteogenic Synergy of Human Mesenchymal Stem Cells and Human Umbilical Vein Endothelial Cells Cocultured on a Nanomatrix
por: Chen, Jun, et al.
Publicado: (2018)

The Incretins and Pancreatic β-Cells: Use of Glucagon-Like Peptide-1 and Glucose-Dependent Insulinotropic Polypeptide to Cure Type 2 Diabetes Mellitus
por: Kim, Mi-Hyun, et al.
Publicado: (2010)

Incretin therapies: highlighting common features and differences in the modes of action of glucagon‐like peptide‐1 receptor agonists and dipeptidyl peptidase‐4 inhibitors
por: Nauck, M.
Publicado: (2016)

Women with COPD by biomass show different serum profile of adipokines, incretins, and peptide hormones than smokers
por: Pérez-Bautista, Oliver, et al.
Publicado: (2018)

Injectable muscle-adhesive antioxidant conductive photothermal bioactive nanomatrix for efficiently promoting full-thickness skeletal muscle regeneration
por: Zhou, Li, et al.
Publicado: (2020)

A unique hormonal recognition feature of the human glucagon-like peptide-2 receptor
por: Sun, Wen, et al.
Publicado: (2020)

Linagliptin Increases Incretin Levels, Lowers Glucagon, and Improves Glycemic Control in Type 2 Diabetes Mellitus
por: Rauch, Thomas, et al.
Publicado: (2012)

Autophagy deficiency in β cells blunts incretin-induced suppression of glucagon release from α cells
por: Kim, Min Joo, et al.
Publicado: (2016)

The role of the Wnt signaling pathway in incretin hormone production and function
por: Chiang, Yu-ting A., et al.
Publicado: (2012)

Relationships Between Gastric Emptying, Postprandial Glycemia, and Incretin Hormones
por: Marathe, Chinmay S., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_pur4j2khj4mvlq3fml2nrpc8gk